June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 03, 2025

Plant Diet May Delay Myeloma Precursor Progression

First clinical trial shows high-fiber plant-based diet improves microbiome and may delay MGUS/SMM progression to multiple myeloma.

Conexiant

June 02, 2025

Understanding the Journey to the Laboratory Matters More Than Ever

Collaborative study provides a data-driven roadmap for safeguarding the pathology workforce

The Pathologist

August 13, 2024

Mass Spec Down Under: IMSC Is Here!

Find out what’s happening at IMSC 2024 with our top selections from the program…

The Pathologist

January 28, 2025

FDA Approves Enhertu for Metastatic, HR-Positive, HER2-Low or -Ultralow Breast Cancer

Enhertu, a HER2-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration for pretreated patients with metastatic HR-positive, HER2-low or HER2-ultralow breast cancer based on results from the DESTINY-Breast06 trial.

Conexiant

March 25, 2025

Microplastics: Chewing Gum May Release Particles Into Saliva

"Surprisingly, both synthetic and natural gums had similar amounts of microplastics released when we chewed them."

Conexiant

December 20, 2023

Hands on at USCAP

Check out our series of videos filmed at USCAP 2023, featuring Epredia and Owkin.

The Pathologist

October 18, 2024

SciX Enters the AI Age

From AI-driven diagnostics to tales of viking treasures, check out our must-see SciX 2024 highlights

The Pathologist

April 30, 2025

AACR 2025: AI-Driven Analysis of Digital Pathology Images May Improve Sarcoma Subtyping Among Pediatric Patients

Researchers explored the potential of a novel artificial intelligence (AI)-based model to classify sarcomas among pediatric patients using digital pathology images alone, according to findings present...

The ASCO Post